Cyagen Biosciences Inc.
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- cyagen.com
- Founded
- 2005
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | -$30,915 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Quick answers
Is Cyagen Biosciences Inc. registered in SAM.gov?
Cyagen Biosciences Inc.'s SAM.gov registration was deleted on December 12, 2018.
What is Cyagen Biosciences Inc.'s CAGE code?
Cyagen Biosciences Inc.'s CAGE code is 6XG19, and its Unique Entity ID (UEI) is EL2WH3GC3LD5.
What is Cyagen Biosciences Inc.'s most recent federal award?
Cyagen Biosciences Inc.'s most recent federal contract award is Cyagen biosciences:1230918 [18-009393] (75N95018P00434), from National Institute on Drug Abuse (NIH), on July 26, 2018.
On GovTribe
See Cyagen Biosciences Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors